AAPL   325.67 (+0.72%)
MSFT   185.29 (+0.21%)
FB   230.64 (-0.89%)
AMZN   2,484.11 (+0.47%)
NVDA   351.99 (-0.29%)
CGC   16.58 (+2.73%)
BABA   218.42 (+1.91%)
MU   49.10 (+4.87%)
GE   7.33 (+3.97%)
TSLA   885.36 (+0.43%)
AMD   52.90 (-1.20%)
T   31.57 (+1.87%)
ACB   14.34 (-1.31%)
F   6.23 (+5.42%)
GILD   74.19 (+1.27%)
DIS   122.22 (+2.92%)
NFLX   424.15 (-0.74%)
BAC   26.04 (+4.83%)
BA   172.79 (+12.71%)
AAPL   325.67 (+0.72%)
MSFT   185.29 (+0.21%)
FB   230.64 (-0.89%)
AMZN   2,484.11 (+0.47%)
NVDA   351.99 (-0.29%)
CGC   16.58 (+2.73%)
BABA   218.42 (+1.91%)
MU   49.10 (+4.87%)
GE   7.33 (+3.97%)
TSLA   885.36 (+0.43%)
AMD   52.90 (-1.20%)
T   31.57 (+1.87%)
ACB   14.34 (-1.31%)
F   6.23 (+5.42%)
GILD   74.19 (+1.27%)
DIS   122.22 (+2.92%)
NFLX   424.15 (-0.74%)
BAC   26.04 (+4.83%)
BA   172.79 (+12.71%)
AAPL   325.67 (+0.72%)
MSFT   185.29 (+0.21%)
FB   230.64 (-0.89%)
AMZN   2,484.11 (+0.47%)
NVDA   351.99 (-0.29%)
CGC   16.58 (+2.73%)
BABA   218.42 (+1.91%)
MU   49.10 (+4.87%)
GE   7.33 (+3.97%)
TSLA   885.36 (+0.43%)
AMD   52.90 (-1.20%)
T   31.57 (+1.87%)
ACB   14.34 (-1.31%)
F   6.23 (+5.42%)
GILD   74.19 (+1.27%)
DIS   122.22 (+2.92%)
NFLX   424.15 (-0.74%)
BAC   26.04 (+4.83%)
BA   172.79 (+12.71%)
AAPL   325.67 (+0.72%)
MSFT   185.29 (+0.21%)
FB   230.64 (-0.89%)
AMZN   2,484.11 (+0.47%)
NVDA   351.99 (-0.29%)
CGC   16.58 (+2.73%)
BABA   218.42 (+1.91%)
MU   49.10 (+4.87%)
GE   7.33 (+3.97%)
TSLA   885.36 (+0.43%)
AMD   52.90 (-1.20%)
T   31.57 (+1.87%)
ACB   14.34 (-1.31%)
F   6.23 (+5.42%)
GILD   74.19 (+1.27%)
DIS   122.22 (+2.92%)
NFLX   424.15 (-0.74%)
BAC   26.04 (+4.83%)
BA   172.79 (+12.71%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Globus MedicalICU MedicalIntegra LifesciencesTandem Diabetes CareHaemonetics
SymbolNYSE:GMEDNASDAQ:ICUINASDAQ:IARTNASDAQ:TNDMNYSE:HAE
Price Information
Current Price$54.95$198.80$54.15$81.42$103.56
52 Week RangeBuyBuyHoldBuyBuy
Beat the Market™ Rank
Overall Score1.61.31.51.31.8
Analysis Score2.41.52.22.34.4
Community Score2.82.52.32.52.2
Dividend Score0.00.00.00.00.0
Ownership Score1.01.01.01.01.0
Earnings & Valuation Score1.91.31.90.61.3
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$57.78$213.50$58.00$88.00$136.83
% Upside from Price Target5.15% upside7.39% upside7.11% upside8.08% upside32.13% upside
Trade Information
Market Cap$5.36 billion$4.21 billion$4.61 billion$4.91 billion$5.53 billion
Beta1.010.551.10.590.71
Average Volume1,457,847187,372558,2981,063,560413,785
Sales & Book Value
Annual Revenue$785.37 million$1.27 billion$1.52 billion$362.30 million$988.48 million
Price / Sales6.833.273.0313.515.27
Cashflow$2.25 per share$11.60 per share$4.22 per shareN/A$5.28 per share
Price / Cash24.4717.1412.82N/A19.63
Book Value$14.05 per share$66.62 per share$16.50 per share$3.30 per share$11.67 per share
Price / Book3.912.983.2824.678.87
Profitability
Net Income$155.21 million$101.04 million$50.20 million$-24,750,000.00$76.53 million
EPS$1.68$7.36$2.74($0.22)$3.31
Trailing P/E Ratio37.9049.21174.68N/A70.45
Forward P/E Ratio30.7030.4019.842,035.5026.55
P/E Growth$5.47N/A$3.94N/A$2.99
Net Margins18.66%6.87%1.76%-4.22%7.74%
Return on Equity (ROE)12.21%10.45%15.98%-9.39%29.33%
Return on Assets (ROA)11.25%8.36%6.64%-5.51%13.83%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A1.25%0.09%0.52%
Current Ratio6.55%2.80%4.09%2.82%2.20%
Quick Ratio4.42%1.93%2.72%2.21%1.21%
Ownership Information
Institutional Ownership Percentage72.97%93.25%83.82%93.44%99.24%
Insider Ownership Percentage24.97%10.90%4.30%6.00%1.32%
Miscellaneous
Employees2,0008,0004,0001,0433,004
Shares Outstanding97.55 million20.83 million84.84 million60.10 million50.30 million
Next Earnings Date8/6/2020 (Estimated)8/5/2020 (Estimated)7/22/2020 (Estimated)8/6/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.